“IN SILICO SCREENING OF EFAVIRENZ AND EFAVIRENZ NICOTINAMIDE COCRYSTAL FOR ITS ACTIVITY AGAINST HIV AND SARS COV-2”. Nirma University Journal of Pharmaceutical Sciences, vol. 10, no. 1, Aug. 2024, pp. 71-86, https://doi.org/10.5281/.